Probiotics: "Living drugs"

American Journal of Health-System Pharmacy

Volumn 58, Issue 12, 2001, Pages 1101-1109

  Elmer, G W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bifidobacterium longum; Enterococcus faecium; Gastrointestinal diseases; Infections; Lactobacillus acidophilus; Lactobacillus rhamnosus; Mechanism of action; Microorganisms; Pediatrics; Saccharomyces boulardii; Toxicity; Travel; Vaginal diseases

Indexed keywords

ANTIINFECTIVE AGENT; FLUCONAZOLE; IMMUNOGLOBULIN A; METRONIDAZOLE; PRIMADOPHILUS REUTERI; PROBIOTIC AGENT; PROBIOTICA; VANCOMYCIN; YOGHURT;

BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM DIFFICILE; COLITIS; DIARRHEA; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; ENTEROCOCCUS FAECIUM; GASTROINTESTINAL INFECTION; HUMAN; INFANTILE DIARRHEA; INFECTION PREVENTION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES BOULARDII; SUPPOSITORY; TRAVELLER DIARRHEA; URINARY TRACT INFECTION; VAGINITIS;

EID: 0035876214     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.12.1101     Document Type: Review

References (102)

1. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina
2. Probiotics in man and animals
3. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections
4. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
5. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin
6. Prebiotics and probiotics: Are they functional foods?
7. A retrospective cohort study of nosocomial diarrhea as a risk factor for nosocomial infection
8. Hospital acquired diarrhea in adults: A prospective case-controlled study in Mexico
9. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea
10. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients
11. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
12. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
13. Diagnosis and treatment of Clostridium difficile colitis
14. Antibiotic-associated diarrhea
15. The epidemiology of Clostridium difficile infections
16. Absorption of short-chain fatty acids by the colon
17. Isolated colonocyte metabolism of glucose, glutamine, n-butyrate, and beta-hydroxybutyrate in malnutrition
18. Impaired colonic fermentation of carbohydrate after ampicillin
19. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea
20. Erythromycin is a motilin receptor agonist
21. Essais cliniques contrôlés en double insu de l'Ultra-Levure Lyophilisée. Étude multicentrique par 25 médecins de 388 cas
22. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
23. Prevention of β-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
24. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
25. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study
26. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea
27. Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation
28. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea
29. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects
30. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
31. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
32. Comment on the lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
33. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea
34. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
35. The ability of probiotic bacteria to bind to human intestinal mucus
36. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers
37. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea
38. The search for a better treatment for recurrent Clostridium difficile disease: The use of high dose vancomycin combined with Saccharomyces boulardii
39. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
40. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
41. Prevention of travellers' diarrhoea by Lactobacillus GG
42. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers
43. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial
44. Lactobacilli to prevent traveler's diarrhea?
45. Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study
46. Diarrhea in developed and developing countries: Magnitude, special settings, and etiologies
47. Persistent diarrhea in northeast Brazil: Etiologies and interactions with malnutrition
48. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children
49. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
50. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
51. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan
52. Lactobacillus GG and acute diarrhoea in young children in the tropics
53. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea
54. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial
55. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
56. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children
57. Evaluación terapéutica de Saccharomyces boulardii en nin̄os con diarrea aguda
58. Saccharomyces boulardii bei akuter Erwachsenendiarrhoe. Wirksamkeit und Verträglichkeit der Behandlung
59. Efficacité de Saccharomyces boulardii dans le traitement des diarrhées du SIDA
60. A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli
61. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri
62. Evaluation of Saccharomyces boulardii for patients with HIV-related chronic diarrhoea and in healthy volunteers receiving antifungals
63. Probiotic use of lactobacilli in the human female urogenital tract
64. Is there a role for lactobacilli in prevention of urogenital and intestinal infections?
65. Biotherapeutic agents as therapy for vaginitis
66. The role of the microflora in bacterial vaginosis
67. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women
68. Bacterial vaginosis in pregnancy treated with yoghurt
69. Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis
70. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophilus and a low dose of estriol: A placebo-controlled multicentric clinical trial
71. Treatment of bacterial vaginosis with lactobacilli
72. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis
73. Lactobacillus GG vaginal suppositories and vaginitis
74. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice
75. Effet comparé de l'administration unique ou en continu de Saccharomyces boulardii sur l'établissement de diverses souches de Candida dans le tractus digestif de souris gnotoxéniques
76. Biotherapeutic agents to prevent cystitis in women
77. Is there a role for lactobacilli in prevention of urogenital and intestinal infections?
78. Adhesion of three Lactobacillus strains to human urinary and intestinal epithelial cells
79. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections
80. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections
81. Influence of three-day antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections
82. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women
83. Production, purification and characterization of reutericin 6, a bacteriocin with lytic activity produced by Lactobacillus reuteri LA6
84. Antimicrobial substance from a human Lactobacillus strain
85. Inhibitory activity of saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro
86. Inhibition of adhesion of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp
87. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum
88. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae
89. Saccharomyces boulardii inhibits secretagoguemediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells
90. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii
91. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea
92. Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats
93. Saccharomyces boulardii enhances rat intestinal enzyme expression of endoluminal release of polyamines
94. Lactobacillemia in three patients with AIDS
95. Lactobacilli and bacteremia in southern Finland, 1989-1992
96. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG
97. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea
98. Are Saccharomyces yeasts harmful to patients?
99. Possible role of catheters in Saccharomyces boulardii fungemia
100. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus